File:Delivery methods for HIV mRNA vaccine.png

From Wikimedia Commons, the free media repository
Jump to navigation Jump to search

Original file(4,005 × 5,289 pixels, file size: 1.06 MB, MIME type: image/png)

Captions

Captions

Delivery methods for HIV mRNA vaccine

Summary[edit]

Description
English: Delivery methods for HIV mRNA vaccine. (A) Electroporation; (B) Cationic micelles composed of stearic acid (yellow) and Polyethylenimine (PEI) (blue); (C) Cationic nanoemulsion (CNE); The yellow core shows squalene. Surfactant such as Tween 80 and Span 85 are shown in blue and purple. Cationic lipid DOTAP (Dioleoyl-3-trimethylammonium propane) is shown with red ‘+’ mark; (D) poly(lactic acid) (PLA) nanoparticle (blue core) with cell penetrating peptide (CPP) (shown in red); (E) Cationic lipid nanoparticle (LNP); figure shows a lipid bilayer with other components that can be included, such as Polyethylene glycol (PEG), cholesterol or phospholipid; (F) Ex vivo loading of dendritic cell (DC). The table below summarizes the HIV mRNA vaccines that have been tested, detailing the delivery method, the type of mRNA, the in vitro and in vivo system used for testing, the mRNA-encoded immunogen and a short note on the results.
Date
Source Mu, Z.; Haynes, B.F.; Cain, D.W. HIV mRNA Vaccines—Progress and Future Paths. Vaccines 2021, 9, 134. https://doi.org/10.3390/vaccines9020134
Author Mu, Z.; Haynes, B.F.; Cain, D.W.

Licensing[edit]

w:en:Creative Commons
attribution
This file is licensed under the Creative Commons Attribution 4.0 International license.
You are free:
  • to share – to copy, distribute and transmit the work
  • to remix – to adapt the work
Under the following conditions:
  • attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current08:38, 29 March 2021Thumbnail for version as of 08:38, 29 March 20214,005 × 5,289 (1.06 MB)Balkanique (talk | contribs)Uploaded a work by Mu, Z.; Haynes, B.F.; Cain, D.W. from Mu, Z.; Haynes, B.F.; Cain, D.W. HIV mRNA Vaccines—Progress and Future Paths. Vaccines 2021, 9, 134. https://doi.org/10.3390/vaccines9020134 with UploadWizard

The following page uses this file: